Manward Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.28 M
as on 18-12-2024
- Revenue 46.24%
(FY 2022)
- Profit 348.08%
(FY 2022)
- Ebitda 152.89%
(FY 2022)
- Net Worth 68.82%
(FY 2022)
- Total Assets -5.91%
(FY 2022)
About Manward Healthcare Products
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.28 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ashok Singh and Rekha Singh serve as directors at the Company.
- CIN/LLPIN
U33110DL2009PTC195305
- Company No.
195305
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Manward Healthcare Products Private Limited offer?
Manward Healthcare Products Private Limited offers a wide range of products and services, including Towels, Napkins & Handkerchieves, Tissue Paper, Face Mask & Medical PPE Kits, Disposable Gloves, Hand Sanitizers & Personal Hygiene, Wet Wipes, Medical Laboratory Instruments, Blood Bank Equipments, Medical Gauze, Alcohol Swab.
Who are the key members and board of directors at Manward Healthcare Products?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Singh  | Director | 16-Oct-2009 | Current |
| Rekha Singh | Director | 16-Oct-2009 | Current |
Financial Performance of Manward Healthcare Products.
Manward Healthcare Products Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 46.24% increase. The company also saw a substantial improvement in profitability, with a 348.08% increase in profit. The company's net worth Soared by an impressive increase of 68.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manward Healthcare Products?
In 2022, Manward Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Maharastra Creation Date: 25 Feb 2010 | ₹0.28 M | Satisfied |
How Many Employees Work at Manward Healthcare Products?
Unlock and access historical data on people associated with Manward Healthcare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manward Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manward Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
